Related Experiment Videos
Immunopathogenesis of Crohn's disease
Thomas T MacDonald1, Antonio Di Sabatino, Antonio DiSabatino
1Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, Southampton, United Kingdom. t.t.macdonald@soton.ac.uk
JPEN. Journal of Parenteral and Enteral Nutrition
|June 28, 2005
Summary
Advances in Crohn's disease research reveal a T helper cell type 1 immune response targeting gut bacteria. Genetic factors and inhibited healing pathways contribute to this inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Crohn's disease involves a polarized T helper cell type 1 immune response in the gut.
- Overexpression of tumor necrosis factor (TNF)-alpha and matrix-degrading enzymes contribute to tissue damage.
- Genetic susceptibility is linked to microbial recognition and epithelial barrier function.
Purpose of the Study:
- To review significant advancements in understanding Crohn's disease pathogenesis over the past 15 years.
- To elucidate the roles of immune responses, genetic factors, and healing pathways in Crohn's disease.
Main Methods:
- Review of recent scientific literature on Crohn's disease.
- Analysis of immunological, genetic, and molecular mechanisms involved in the disease.
Main Results:
- The disease pathogenesis involves a specific T helper cell type 1 response against commensal flora antigens.
- Key genes like Nod2, OCTN, and DLG5 are associated with susceptibility.
- Transforming growth factor (TGF)-beta1 mediated healing is inhibited by Smad7 expression.
Conclusions:
- Crohn's disease involves complex interactions between genetic predisposition, immune dysregulation, and impaired mucosal healing.
- While direct anti-inflammatory effects of TGF-beta in enteral feeds are unlikely, its role in mucosal healing warrants further investigation.
- Dietary changes may influence mucosal healing synergistically with TGF-beta by altering bacterial populations.